Tsutani Y - Search Results

1

Tsutani Y, Okada M. Tsutani Y, et al. Thorac Surg Clin. 2018 Aug;28(3):299-304. doi: 10.1016/j.thorsurg.2018.04.002. Thorac Surg Clin. 2018. PMID: 30054067 Review.

2

Performance of Ultra-Rapid Idylla™ EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening.

Suda K, Sakai K, Ohira T, Chikugo T, Satou T, Matsubayashi J, Nagao T, Ikeda N, Tsutani Y, Mitsudomi T, Nishio K. Suda K, et al. Among authors: tsutani y. Cancers (Basel). 2023 May 7;15(9):2648. doi: 10.3390/cancers15092648. Cancers (Basel). 2023. PMID: 37174112 Free PMC article.

3

Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2-IA3 EGFR-Mutated NSCLC: ADAURA2.

Tsutani Y, Goldman JW, Dacic S, Yatabe Y, Majem M, Huang X, Chen A, van der Gronde T, He J. Tsutani Y, et al. Clin Lung Cancer. 2023 Jun;24(4):376-380. doi: 10.1016/j.cllc.2023.02.002. Epub 2023 Feb 8. Clin Lung Cancer. 2023. PMID: 36872181 Free article.

4

Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line.

Tsutani Y, Yoshida K, Sanada Y, Wada Y, Konishi K, Fukushima M, Okada M. Tsutani Y, et al. Oncol Rep. 2008 Dec;20(6):1545-51. Oncol Rep. 2008. PMID: 19020740

5

Dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in esophageal cancer patients: Correlation with clinicopathological factors and prognosis.

Tsutani Y, Yoshida K, Sanada Y, Oeda M, Suzuki T, Hihara J, Okada M. Tsutani Y, et al. Mol Med Rep. 2008 Sep-Oct;1(5):713-9. doi: 10.3892/mmr_00000018. Mol Med Rep. 2008. PMID: 21479475

6

Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung.

Tsutani Y, Miyata Y, Misumi K, Ikeda T, Mimura T, Hihara J, Okada M. Tsutani Y, et al. Jpn J Clin Oncol. 2011 Jul;41(7):890-6. doi: 10.1093/jjco/hyr062. Epub 2011 May 25. Jpn J Clin Oncol. 2011. PMID: 21613306

7

Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M. Tsutani Y, et al. J Thorac Cardiovasc Surg. 2012 Mar;143(3):607-12. doi: 10.1016/j.jtcvs.2011.10.037. Epub 2011 Nov 20. J Thorac Cardiovasc Surg. 2012. PMID: 22104678 Free article.

8

Radical hybrid video-assisted thoracic segmentectomy: long-term results of minimally invasive anatomical sublobar resection for treating lung cancer.

Okada M, Tsutani Y, Ikeda T, Misumi K, Matsumoto K, Yoshimura M, Miyata Y. Okada M, et al. Among authors: tsutani y. Interact Cardiovasc Thorac Surg. 2012 Jan;14(1):5-11. doi: 10.1093/icvts/ivr065. Epub 2011 Nov 17. Interact Cardiovasc Thorac Surg. 2012. PMID: 22108951 Free PMC article.

9

Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages.

Mimae T, Okada M, Hagiyama M, Miyata Y, Tsutani Y, Inoue T, Murakami Y, Ito A. Mimae T, et al. Among authors: tsutani y. Clin Cancer Res. 2012 Feb 15;18(4):945-55. doi: 10.1158/1078-0432.CCR-11-1946. Epub 2011 Dec 21. Clin Cancer Res. 2012. PMID: 22190591

10

Fibrinogen/thrombin-based collagen fleece (TachoComb(R)) promotes regeneration in pulmonary arterial injury.

Ikeda T, Miyata Y, Tsutani Y, Misumi K, Arihiro K, Okada M. Ikeda T, et al. Among authors: tsutani y. Eur J Cardiothorac Surg. 2012 Apr;41(4):926-32. doi: 10.1093/ejcts/ezr128. Epub 2011 Dec 21. Eur J Cardiothorac Surg. 2012. PMID: 22219426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters